Your browser doesn't support javascript.
loading
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Zaloga, Jan; Pöttler, Marina; Leitinger, Gerd; Friedrich, Ralf P; Almer, Gunter; Lyer, Stefan; Baum, Eva; Tietze, Rainer; Heimke-Brinck, Ralph; Mangge, Harald; Dörje, Frank; Lee, Geoffrey; Alexiou, Christoph.
Afiliação
  • Zaloga J; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany.
  • Pöttler M; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany.
  • Leitinger G; Institute of Cell Biology, Histology, and Embryology, Medical University of Graz, Graz, Austria; Center for Medical Research, Medical University of Graz, Graz, Austria.
  • Friedrich RP; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany.
  • Almer G; Center for Medical Research, Medical University of Graz, Graz, Austria; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Lyer S; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany.
  • Baum E; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany.
  • Tietze R; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany.
  • Heimke-Brinck R; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany.
  • Mangge H; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Dörje F; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany.
  • Lee G; Division of Pharmaceutics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Alexiou C; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, University Hospital Erlangen, Erlangen, Germany. Electronic address: c.alexiou@web.de.
Eur J Pharm Biopharm ; 101: 152-62, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26854862
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albumina Sérica / Compostos Férricos / Nanopartículas Limite: Humans Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albumina Sérica / Compostos Férricos / Nanopartículas Limite: Humans Idioma: En Revista: Eur J Pharm Biopharm Ano de publicação: 2016 Tipo de documento: Article